2015-2027 Global Acute Spinal Cord Injury Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 131 pages | ID: 252981278D40EN
Maia Research

Abstracts

The worldwide market for Acute Spinal Cord Injury is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
BIOTIME, INC.
Acorda Therapeutics, Inc.
Neuralstem, Inc.
Mitsubishi Tanabe Pharma Corporation
Histocell
BioAxone
Pfizer

Major Types Covered
laboratory tests
Imaging tests

Major Applications Covered
Hospitals & Clinics
Ambulatory centers

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Acute Spinal Cord Injury Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Acute Spinal Cord Injury Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE ACUTE SPINAL CORD INJURY MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL ACUTE SPINAL CORD INJURY MARKET-SEGMENTATION BY TYPE

5.1 laboratory tests
5.2 Imaging tests

6 GLOBAL ACUTE SPINAL CORD INJURY MARKET-SEGMENTATION BY APPLICATION

6.1 Hospitals & Clinics
6.2 Ambulatory centers

7 GLOBAL ACUTE SPINAL CORD INJURY MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 BIOTIME, INC.
  8.1.1 BIOTIME, INC. Profile
  8.1.2 BIOTIME, INC. Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 BIOTIME, INC. Product/Solution Launches and Enhancements Analysis
  8.1.4 BIOTIME, INC. Business Overview/Recent Development/Acquisitions
8.2 Acorda Therapeutics, Inc.
  8.2.1 Acorda Therapeutics, Inc. Profile
  8.2.2 Acorda Therapeutics, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Acorda Therapeutics, Inc. Product/Solution Launches and Enhancements Analysis
  8.2.4 Acorda Therapeutics, Inc. Business Overview/Recent Development/Acquisitions
8.3 Neuralstem, Inc.
  8.3.1 Neuralstem, Inc. Profile
  8.3.2 Neuralstem, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Neuralstem, Inc. Product/Solution Launches and Enhancements Analysis
  8.3.4 Neuralstem, Inc. Business Overview/Recent Development/Acquisitions
8.4 Mitsubishi Tanabe Pharma Corporation
  8.4.1 Mitsubishi Tanabe Pharma Corporation Profile
  8.4.2 Mitsubishi Tanabe Pharma Corporation Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Mitsubishi Tanabe Pharma Corporation Product/Solution Launches and Enhancements Analysis
  8.4.4 Mitsubishi Tanabe Pharma Corporation Business Overview/Recent Development/Acquisitions
8.5 Histocell
  8.5.1 Histocell Profile
  8.5.2 Histocell Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Histocell Product/Solution Launches and Enhancements Analysis
  8.5.4 Histocell Business Overview/Recent Development/Acquisitions
8.6 BioAxone
  8.6.1 BioAxone Profile
  8.6.2 BioAxone Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 BioAxone Product/Solution Launches and Enhancements Analysis
  8.6.4 BioAxone Business Overview/Recent Development/Acquisitions
8.7 Pfizer
  8.7.1 Pfizer Profile
  8.7.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.7.4 Pfizer Business Overview/Recent Development/Acquisitions

9 GLOBAL ACUTE SPINAL CORD INJURY MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Acute Spinal Cord Injury Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Acute Spinal Cord Injury Production Analysis from 2015-2020
10.4 North America Acute Spinal Cord Injury Consumption Analysis from 2015-2020
10.5 North America Acute Spinal Cord Injury Import and Export from 2015-2020
10.6 North America Acute Spinal Cord Injury Value, Production and Market Share by Type (2015-2020)
10.7 North America Acute Spinal Cord Injury Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Acute Spinal Cord Injury by Country (United States, Canada)
  10.8.1 North America Acute Spinal Cord Injury Sales by Country (2015-2020)
  10.8.2 North America Acute Spinal Cord Injury Consumption Value by Country (2015-2020)
10.9 North America Acute Spinal Cord Injury Market PEST Analysis

11 EUROPE

11.1 Europe Acute Spinal Cord Injury Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Acute Spinal Cord Injury Production Analysis from 2015-2020
11.4 Europe Acute Spinal Cord Injury Consumption Analysis from 2015-2020
11.5 Europe Acute Spinal Cord Injury Import and Export from 2015-2020
11.6 Europe Acute Spinal Cord Injury Value, Production and Market Share by Type (2015-2020)
11.7 Europe Acute Spinal Cord Injury Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Acute Spinal Cord Injury by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Acute Spinal Cord Injury Sales by Country (2015-2020)
  11.8.2 Europe Acute Spinal Cord Injury Consumption Value by Country (2015-2020)
11.9 Europe Acute Spinal Cord Injury Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Acute Spinal Cord Injury Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Acute Spinal Cord Injury Production Analysis from 2015-2020
12.4 Asia-Pacific Acute Spinal Cord Injury Consumption Analysis from 2015-2020
12.5 Asia-Pacific Acute Spinal Cord Injury Import and Export from 2015-2020
12.6 Asia-Pacific Acute Spinal Cord Injury Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Acute Spinal Cord Injury Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Acute Spinal Cord Injury by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Acute Spinal Cord Injury Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Acute Spinal Cord Injury Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Acute Spinal Cord Injury Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Acute Spinal Cord Injury Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Acute Spinal Cord Injury Production Analysis from 2015-2020
13.4 Latin America Acute Spinal Cord Injury Consumption Analysis from 2015-2020
13.5 Latin America Acute Spinal Cord Injury Import and Export from 2015-2020
13.6 Latin America Acute Spinal Cord Injury Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Acute Spinal Cord Injury Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Acute Spinal Cord Injury by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Acute Spinal Cord Injury Sales by Country (2015-2020)
  13.8.2 Latin America Acute Spinal Cord Injury Consumption Value by Country (2015-2020)
13.9 Latin America Acute Spinal Cord Injury Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Acute Spinal Cord Injury Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Acute Spinal Cord Injury Production Analysis from 2015-2020
14.4 Middle East & Africa Acute Spinal Cord Injury Consumption Analysis from 2015-2020
14.5 Middle East & Africa Acute Spinal Cord Injury Import and Export from 2015-2020
14.6 Middle East & Africa Acute Spinal Cord Injury Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Acute Spinal Cord Injury Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Acute Spinal Cord Injury by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Acute Spinal Cord Injury Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Acute Spinal Cord Injury Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Acute Spinal Cord Injury Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL ACUTE SPINAL CORD INJURY MARKET FROM 2020-2027

15.1 Future Forecast of the Global Acute Spinal Cord Injury Market from 2020-2027 Segment by Region
15.2 Global Acute Spinal Cord Injury Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Acute Spinal Cord Injury Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Acute Spinal Cord Injury Market Value ($) and Growth Rate of Acute Spinal Cord Injury from 2015-2027
Global Acute Spinal Cord Injury Production and Growth Rate Segment by Product Type from 2015-2027
Global Acute Spinal Cord Injury Consumption and Growth Rate Segment by Application from 2015-2027
Figure Acute Spinal Cord Injury Picture
Table Product Specifications of Acute Spinal Cord Injury
Table Driving Factors for this Market
Table Industry News of Acute Spinal Cord Injury Market
Figure Value Chain Status of Acute Spinal Cord Injury
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Acute Spinal Cord Injury Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Acute Spinal Cord Injury Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure laboratory tests of Acute Spinal Cord Injury
Figure Imaging tests of Acute Spinal Cord Injury
Table Global Acute Spinal Cord Injury Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Acute Spinal Cord Injury Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospitals & Clinics of Acute Spinal Cord Injury
Figure Ambulatory centers of Acute Spinal Cord Injury
Table Global Acute Spinal Cord Injury Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Acute Spinal Cord Injury Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Acute Spinal Cord Injury
Figure Online Channel of Acute Spinal Cord Injury
Table BIOTIME, INC. Profile (Company Name, Plants Distribution, Sales Region)
Figure BIOTIME, INC. Sales and Growth Rate from 2015-2020
Figure BIOTIME, INC. Revenue ($) and Global Market Share from 2015-2020
Table BIOTIME, INC. Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table Acorda Therapeutics, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Acorda Therapeutics, Inc. Sales and Growth Rate from 2015-2020
Figure Acorda Therapeutics, Inc. Revenue ($) and Global Market Share from 2015-2020
Table Acorda Therapeutics, Inc. Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table Neuralstem, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Neuralstem, Inc. Sales and Growth Rate from 2015-2020
Figure Neuralstem, Inc. Revenue ($) and Global Market Share from 2015-2020
Table Neuralstem, Inc. Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table Mitsubishi Tanabe Pharma Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Mitsubishi Tanabe Pharma Corporation Sales and Growth Rate from 2015-2020
Figure Mitsubishi Tanabe Pharma Corporation Revenue ($) and Global Market Share from 2015-2020
Table Mitsubishi Tanabe Pharma Corporation Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table Histocell Profile (Company Name, Plants Distribution, Sales Region)
Figure Histocell Sales and Growth Rate from 2015-2020
Figure Histocell Revenue ($) and Global Market Share from 2015-2020
Table Histocell Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table BioAxone Profile (Company Name, Plants Distribution, Sales Region)
Figure BioAxone Sales and Growth Rate from 2015-2020
Figure BioAxone Revenue ($) and Global Market Share from 2015-2020
Table BioAxone Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Acute Spinal Cord Injury Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Acute Spinal Cord Injury Production Value ($) by Region from 2015-2020
Table Global Acute Spinal Cord Injury Production Value Share by Region from 2015-2020
Table Global Acute Spinal Cord Injury Production by Region from 2015-2020
Table Global Acute Spinal Cord Injury Consumption Value ($) by Region from 2015-2020
Table Global Acute Spinal Cord Injury Consumption by Region from 2015-2020
Table North America Acute Spinal Cord Injury Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Acute Spinal Cord Injury Import and Export from 2015-2020
Table North America Acute Spinal Cord Injury Value ($) by Type (2015-2020)
Table North America Acute Spinal Cord Injury Production by Type (2015-2020)
Table North America Acute Spinal Cord Injury Consumption by Application (2015-2020)
Table North America Acute Spinal Cord Injury Consumption by Country (2015-2020)
Table North America Acute Spinal Cord Injury Consumption Value ($) by Country (2015-2020)
Figure North America Acute Spinal Cord Injury Market PEST Analysis
Table Europe Acute Spinal Cord Injury Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Acute Spinal Cord Injury Import and Export from 2015-2020
Table Europe Acute Spinal Cord Injury Value ($) by Type (2015-2020)
Table Europe Acute Spinal Cord Injury Production by Type (2015-2020)
Table Europe Acute Spinal Cord Injury Consumption by Application (2015-2020)
Table Europe Acute Spinal Cord Injury Consumption by Country (2015-2020)
Table Europe Acute Spinal Cord Injury Consumption Value ($) by Country (2015-2020)
Figure Europe Acute Spinal Cord Injury Market PEST Analysis
Table Asia-Pacific Acute Spinal Cord Injury Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Acute Spinal Cord Injury Import and Export from 2015-2020
Table Asia-Pacific Acute Spinal Cord Injury Value ($) by Type (2015-2020)
Table Asia-Pacific Acute Spinal Cord Injury Production by Type (2015-2020)
Table Asia-Pacific Acute Spinal Cord Injury Consumption by Application (2015-2020)
Table Asia-Pacific Acute Spinal Cord Injury Consumption by Country (2015-2020)
Table Asia-Pacific Acute Spinal Cord Injury Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Acute Spinal Cord Injury Market PEST Analysis
Table Latin America Acute Spinal Cord Injury Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Acute Spinal Cord Injury Import and Export from 2015-2020
Table Latin America Acute Spinal Cord Injury Value ($) by Type (2015-2020)
Table Latin America Acute Spinal Cord Injury Production by Type (2015-2020)
Table Latin America Acute Spinal Cord Injury Consumption by Application (2015-2020)
Table Latin America Acute Spinal Cord Injury Consumption by Country (2015-2020)
Table Latin America Acute Spinal Cord Injury Consumption Value ($) by Country (2015-2020)
Figure Latin America Acute Spinal Cord Injury Market PEST Analysis
Table Middle East & Africa Acute Spinal Cord Injury Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Acute Spinal Cord Injury Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Acute Spinal Cord Injury Import and Export from 2015-2020
Table Middle East & Africa Acute Spinal Cord Injury Value ($) by Type (2015-2020)
Table Middle East & Africa Acute Spinal Cord Injury Production by Type (2015-2020)
Table Middle East & Africa Acute Spinal Cord Injury Consumption by Application (2015-2020)
Table Middle East & Africa Acute Spinal Cord Injury Consumption by Country (2015-2020)
Table Middle East & Africa Acute Spinal Cord Injury Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Acute Spinal Cord Injury Market PEST Analysis
Table Global Acute Spinal Cord Injury Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Acute Spinal Cord Injury Production and Growth Rate Forecast by Region (2020-2027)
Table Global Acute Spinal Cord Injury Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Acute Spinal Cord Injury Production and Growth Rate Forecast by Type (2020-2027)
Table Global Acute Spinal Cord Injury Consumption and Growth Rate Forecast by Application (2020-2027)